Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-12

AUTHORS

Madhav Prasad Yadav, Sanjana Ballal, Chandrasekhar Bal

ABSTRACT

BACKGROUND: The role of concomitant peptide receptor radionuclide therapy (PRRT) and capecitabine therapy has shown benefit in gastroenteropancreatic neuroendocrine tumors. However, data reporting its role in paraganglioma (PGL) patients is lacking. The aim of this study was to evaluate the role of combined capecitabine and 177Lu-DOTATATE in malignant PGL patients. METHODS: In this retrospective, single-institutional, single-arm, observational study, data of consecutive advanced stage PGL patients treated with concomitant 177Lu-DOTATATE-capecitabine therapy, between July 2009 and March 2017, were collected and analyzed. RESULTS: Twenty-five PGL patients received an average dose of 22.86 ± 9.54 (14.43-50) GBq 177Lu-DOTATATE and 1250 mg/m2 capecitabine from days 0 to 14, commencing on the morning of PRRT. The median overall survival (OS) was not attained in this patient cohort; however, the median PFS was 32 months. Morphological response according to RECIST 1.1 criteria was achieved in 28% (7/25) patients. Biochemical response with > 50% reduction in chromogranin A levels was observed in 28% of the patients. CONCLUSIONS: Our data confirm that 177Lu-DOTATATE-capecitabine therapy is effective in achieving an objective response in 28% and symptomatic response in 43% patients. In comparison to published PRRT monotherapy outcomes in PGL, we did not observe any great advantage of concomitant therapy; however, it could be due to under-powered study. We recommend a large randomized trial to prove or disprove the utility of capecitabine as a radiosensitizer for PRRT in PGL patients. More... »

PAGES

13

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13550-019-0484-y

DOI

http://dx.doi.org/10.1186/s13550-019-0484-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111933438

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30725219


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "All India Institute of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.413618.9", 
          "name": [
            "Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, 110029, New Delhi, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yadav", 
        "givenName": "Madhav Prasad", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "All India Institute of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.413618.9", 
          "name": [
            "Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, 110029, New Delhi, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ballal", 
        "givenName": "Sanjana", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "All India Institute of Medical Sciences", 
          "id": "https://www.grid.ac/institutes/grid.413618.9", 
          "name": [
            "Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, 110029, New Delhi, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bal", 
        "givenName": "Chandrasekhar", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1196/annals.1353.005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000088566"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00439229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004879799", 
          "https://doi.org/10.1007/bf00439229"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00439229", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004879799", 
          "https://doi.org/10.1007/bf00439229"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3389/fonc.2014.00166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005638342"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/j.semnuclmed.2016.01.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005863057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1607427", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006939647"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(05)67139-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007382335"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(05)67139-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007382335"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12032-016-0737-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010835416", 
          "https://doi.org/10.1007/s12032-016-0737-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2735-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014772803", 
          "https://doi.org/10.1007/s00259-014-2735-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.3496", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017623698"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00944177", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017722235", 
          "https://doi.org/10.1007/bf00944177"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-011-1902-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019962478", 
          "https://doi.org/10.1007/s00259-011-1902-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/ejso.2002.1413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021588970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1053/ejso.2002.1413", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021588970"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-007-0652-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034513211", 
          "https://doi.org/10.1007/s00259-007-0652-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0039-6060(03)00426-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038182912"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1677/erc-09-0078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039970480"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/cen.12341", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047516398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0032-1308992", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057259445"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1055/s-0032-1311637", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1057261777"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/cbr.2010.0881", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059243112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2012-2356", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064293700"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1542/peds.2005-2299", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067824727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1999.17.3.1008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074262187"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077303934", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077649208", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.24553", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083686965"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2017-00816", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085975247"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000001816", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091472779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000001816", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091472779"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/rlu.0000000000001816", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091472779"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "BACKGROUND: The role of concomitant peptide receptor radionuclide therapy (PRRT) and capecitabine therapy has shown benefit in gastroenteropancreatic neuroendocrine tumors. However, data reporting its role in paraganglioma (PGL) patients is lacking. The aim of this study was to evaluate the role of combined capecitabine and 177Lu-DOTATATE in malignant PGL patients.\nMETHODS: In this retrospective, single-institutional, single-arm, observational study, data of consecutive advanced stage PGL patients treated with concomitant 177Lu-DOTATATE-capecitabine therapy, between July 2009 and March 2017, were collected and analyzed.\nRESULTS: Twenty-five PGL patients received an average dose of 22.86\u2009\u00b1\u20099.54 (14.43-50) GBq 177Lu-DOTATATE and 1250\u2009mg/m2 capecitabine from days 0 to 14, commencing on the morning of PRRT. The median overall survival (OS) was not attained in this patient cohort; however, the median PFS was 32\u2009months. Morphological response according to RECIST 1.1 criteria was achieved in 28% (7/25) patients. Biochemical response with >\u200950% reduction in chromogranin A levels was observed in 28% of the patients.\nCONCLUSIONS: Our data confirm that 177Lu-DOTATATE-capecitabine therapy is effective in achieving an objective response in 28% and symptomatic response in 43% patients. In comparison to published PRRT monotherapy outcomes in PGL, we did not observe any great advantage of concomitant therapy; however, it could be due to under-powered study. We recommend a large randomized trial to prove or disprove the utility of capecitabine as a radiosensitizer for PRRT in PGL patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13550-019-0484-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1045165", 
        "issn": [
          "2191-219X"
        ], 
        "name": "EJNMMI Research", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "9"
      }
    ], 
    "name": "Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas", 
    "pagination": "13", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "35157830296a7cb74bfb6f03bbaceaa7e158594844ab3bbfae2f9c56bd9f28d4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30725219"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101560946"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13550-019-0484-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111933438"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13550-019-0484-y", 
      "https://app.dimensions.ai/details/publication/pub.1111933438"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113658_00000005.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13550-019-0484-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0484-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0484-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0484-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13550-019-0484-y'


 

This table displays all metadata directly associated to this object as RDF triples.

167 TRIPLES      21 PREDICATES      57 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13550-019-0484-y schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N79cb3aa4eff44e06bbaaa008463e1c92
4 schema:citation sg:pub.10.1007/bf00439229
5 sg:pub.10.1007/bf00944177
6 sg:pub.10.1007/s00259-007-0652-6
7 sg:pub.10.1007/s00259-011-1902-1
8 sg:pub.10.1007/s00259-014-2735-5
9 sg:pub.10.1007/s12032-016-0737-9
10 https://app.dimensions.ai/details/publication/pub.1077303934
11 https://app.dimensions.ai/details/publication/pub.1077649208
12 https://doi.org/10.1002/jso.24553
13 https://doi.org/10.1016/s0039-6060(03)00426-4
14 https://doi.org/10.1016/s0140-6736(05)67139-5
15 https://doi.org/10.1053/ejso.2002.1413
16 https://doi.org/10.1053/j.semnuclmed.2016.01.011
17 https://doi.org/10.1055/s-0032-1308992
18 https://doi.org/10.1055/s-0032-1311637
19 https://doi.org/10.1056/nejmoa1607427
20 https://doi.org/10.1089/cbr.2010.0881
21 https://doi.org/10.1093/jnci/92.3.205
22 https://doi.org/10.1097/rlu.0000000000001816
23 https://doi.org/10.1111/cen.12341
24 https://doi.org/10.1196/annals.1353.005
25 https://doi.org/10.1200/jco.1999.17.3.1008
26 https://doi.org/10.1200/jco.2008.21.3496
27 https://doi.org/10.1210/jc.2012-2356
28 https://doi.org/10.1210/jc.2017-00816
29 https://doi.org/10.1542/peds.2005-2299
30 https://doi.org/10.1677/erc-09-0078
31 https://doi.org/10.3389/fonc.2014.00166
32 schema:datePublished 2019-12
33 schema:datePublishedReg 2019-12-01
34 schema:description BACKGROUND: The role of concomitant peptide receptor radionuclide therapy (PRRT) and capecitabine therapy has shown benefit in gastroenteropancreatic neuroendocrine tumors. However, data reporting its role in paraganglioma (PGL) patients is lacking. The aim of this study was to evaluate the role of combined capecitabine and 177Lu-DOTATATE in malignant PGL patients. METHODS: In this retrospective, single-institutional, single-arm, observational study, data of consecutive advanced stage PGL patients treated with concomitant 177Lu-DOTATATE-capecitabine therapy, between July 2009 and March 2017, were collected and analyzed. RESULTS: Twenty-five PGL patients received an average dose of 22.86 ± 9.54 (14.43-50) GBq 177Lu-DOTATATE and 1250 mg/m2 capecitabine from days 0 to 14, commencing on the morning of PRRT. The median overall survival (OS) was not attained in this patient cohort; however, the median PFS was 32 months. Morphological response according to RECIST 1.1 criteria was achieved in 28% (7/25) patients. Biochemical response with > 50% reduction in chromogranin A levels was observed in 28% of the patients. CONCLUSIONS: Our data confirm that 177Lu-DOTATATE-capecitabine therapy is effective in achieving an objective response in 28% and symptomatic response in 43% patients. In comparison to published PRRT monotherapy outcomes in PGL, we did not observe any great advantage of concomitant therapy; however, it could be due to under-powered study. We recommend a large randomized trial to prove or disprove the utility of capecitabine as a radiosensitizer for PRRT in PGL patients.
35 schema:genre research_article
36 schema:inLanguage en
37 schema:isAccessibleForFree false
38 schema:isPartOf Na8fed7fcf0284c53b760aa784725dfd8
39 Nbd12b4af19824f0ea5d58db394f65aae
40 sg:journal.1045165
41 schema:name Concomitant 177Lu-DOTATATE and capecitabine therapy in malignant paragangliomas
42 schema:pagination 13
43 schema:productId N0b72e6164d9e48949df7686dc75e68f4
44 N363d4379a5364b5ca39584889f4c2a14
45 N6daddfdc6e864e768cb648a1161c8025
46 N78ecf6b0dec940abbf2970ffe7e23c46
47 Nd02d7f9be94e4e5fb503a2b6b2aa73e7
48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111933438
49 https://doi.org/10.1186/s13550-019-0484-y
50 schema:sdDatePublished 2019-04-11T10:33
51 schema:sdLicense https://scigraph.springernature.com/explorer/license/
52 schema:sdPublisher Nefa384e2d9724afcbdd43bb9795c568e
53 schema:url https://link.springer.com/10.1186%2Fs13550-019-0484-y
54 sgo:license sg:explorer/license/
55 sgo:sdDataset articles
56 rdf:type schema:ScholarlyArticle
57 N0b72e6164d9e48949df7686dc75e68f4 schema:name dimensions_id
58 schema:value pub.1111933438
59 rdf:type schema:PropertyValue
60 N100062afd939471d8c6e812c8543ac7a schema:affiliation https://www.grid.ac/institutes/grid.413618.9
61 schema:familyName Ballal
62 schema:givenName Sanjana
63 rdf:type schema:Person
64 N363d4379a5364b5ca39584889f4c2a14 schema:name doi
65 schema:value 10.1186/s13550-019-0484-y
66 rdf:type schema:PropertyValue
67 N6daddfdc6e864e768cb648a1161c8025 schema:name pubmed_id
68 schema:value 30725219
69 rdf:type schema:PropertyValue
70 N78ecf6b0dec940abbf2970ffe7e23c46 schema:name readcube_id
71 schema:value 35157830296a7cb74bfb6f03bbaceaa7e158594844ab3bbfae2f9c56bd9f28d4
72 rdf:type schema:PropertyValue
73 N79cb3aa4eff44e06bbaaa008463e1c92 rdf:first N8ee7e529313e4661a5fb78e3ac3fcfa3
74 rdf:rest N8329c1dcde6c479e9be3afb5822bcc40
75 N8329c1dcde6c479e9be3afb5822bcc40 rdf:first N100062afd939471d8c6e812c8543ac7a
76 rdf:rest Nf7eb1da9af784b49bd31381d3f98d123
77 N8ee7e529313e4661a5fb78e3ac3fcfa3 schema:affiliation https://www.grid.ac/institutes/grid.413618.9
78 schema:familyName Yadav
79 schema:givenName Madhav Prasad
80 rdf:type schema:Person
81 Na8fed7fcf0284c53b760aa784725dfd8 schema:volumeNumber 9
82 rdf:type schema:PublicationVolume
83 Nbd12b4af19824f0ea5d58db394f65aae schema:issueNumber 1
84 rdf:type schema:PublicationIssue
85 Nd02d7f9be94e4e5fb503a2b6b2aa73e7 schema:name nlm_unique_id
86 schema:value 101560946
87 rdf:type schema:PropertyValue
88 Nea7ed4e4519d4837bd8cbf026b54c5a5 schema:affiliation https://www.grid.ac/institutes/grid.413618.9
89 schema:familyName Bal
90 schema:givenName Chandrasekhar
91 rdf:type schema:Person
92 Nefa384e2d9724afcbdd43bb9795c568e schema:name Springer Nature - SN SciGraph project
93 rdf:type schema:Organization
94 Nf7eb1da9af784b49bd31381d3f98d123 rdf:first Nea7ed4e4519d4837bd8cbf026b54c5a5
95 rdf:rest rdf:nil
96 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
97 schema:name Medical and Health Sciences
98 rdf:type schema:DefinedTerm
99 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
100 schema:name Clinical Sciences
101 rdf:type schema:DefinedTerm
102 sg:journal.1045165 schema:issn 2191-219X
103 schema:name EJNMMI Research
104 rdf:type schema:Periodical
105 sg:pub.10.1007/bf00439229 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004879799
106 https://doi.org/10.1007/bf00439229
107 rdf:type schema:CreativeWork
108 sg:pub.10.1007/bf00944177 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017722235
109 https://doi.org/10.1007/bf00944177
110 rdf:type schema:CreativeWork
111 sg:pub.10.1007/s00259-007-0652-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034513211
112 https://doi.org/10.1007/s00259-007-0652-6
113 rdf:type schema:CreativeWork
114 sg:pub.10.1007/s00259-011-1902-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019962478
115 https://doi.org/10.1007/s00259-011-1902-1
116 rdf:type schema:CreativeWork
117 sg:pub.10.1007/s00259-014-2735-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014772803
118 https://doi.org/10.1007/s00259-014-2735-5
119 rdf:type schema:CreativeWork
120 sg:pub.10.1007/s12032-016-0737-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010835416
121 https://doi.org/10.1007/s12032-016-0737-9
122 rdf:type schema:CreativeWork
123 https://app.dimensions.ai/details/publication/pub.1077303934 schema:CreativeWork
124 https://app.dimensions.ai/details/publication/pub.1077649208 schema:CreativeWork
125 https://doi.org/10.1002/jso.24553 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083686965
126 rdf:type schema:CreativeWork
127 https://doi.org/10.1016/s0039-6060(03)00426-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038182912
128 rdf:type schema:CreativeWork
129 https://doi.org/10.1016/s0140-6736(05)67139-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007382335
130 rdf:type schema:CreativeWork
131 https://doi.org/10.1053/ejso.2002.1413 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021588970
132 rdf:type schema:CreativeWork
133 https://doi.org/10.1053/j.semnuclmed.2016.01.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005863057
134 rdf:type schema:CreativeWork
135 https://doi.org/10.1055/s-0032-1308992 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057259445
136 rdf:type schema:CreativeWork
137 https://doi.org/10.1055/s-0032-1311637 schema:sameAs https://app.dimensions.ai/details/publication/pub.1057261777
138 rdf:type schema:CreativeWork
139 https://doi.org/10.1056/nejmoa1607427 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006939647
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1089/cbr.2010.0881 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059243112
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1097/rlu.0000000000001816 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091472779
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1111/cen.12341 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047516398
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1196/annals.1353.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000088566
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1200/jco.1999.17.3.1008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074262187
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1200/jco.2008.21.3496 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017623698
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1210/jc.2012-2356 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064293700
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1210/jc.2017-00816 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085975247
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1542/peds.2005-2299 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067824727
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1677/erc-09-0078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039970480
162 rdf:type schema:CreativeWork
163 https://doi.org/10.3389/fonc.2014.00166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005638342
164 rdf:type schema:CreativeWork
165 https://www.grid.ac/institutes/grid.413618.9 schema:alternateName All India Institute of Medical Sciences
166 schema:name Department of Nuclear Medicine, All India Institute of Medical Sciences, Ansari Nagar, 110029, New Delhi, India
167 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...